Zura Bio
Megan Weinshank is the current Head of Corporate Planning & Chief of Staff at Zura Bio Limited. Prior to this role, she worked as the Senior Director of Corporate Planning & Governance at Emergent BioSolutions and as the Director of Enterprise Program Management at Arena Pharmaceuticals, Inc. She also held various positions at BASF, the US Navy, and Pfizer, where she gained experience in business development, program management, and scientific research. Megan holds a Bachelor of Science in Biochemistry from UC San Diego, a Bachelor of Science in Nuclear Engineering from Excelsior University, and a Master of Business Administration (MBA) from Excelsior University.
This person is not in the org chart
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.